Steven George Hughes sold $90k of RNA
Chief Medical Officer at Avidity Biosciences, Inc.. 2,208 shares at an average of $40.58, traded Sep 22, 2025, filed Sep 23, 2025.
Score components
- +15RoleOfficer
- +9Trade size$90k at market
- 0Share of holdings soldSold 5.4% of holdings
- +15Cluster4 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001599901-25-000190, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 22, 2025 | MOption exercise Common Stock10b5-1 | +2,208 | $10.16 | $22k | 41,075 | Sep 23, 2025 |
| Sep 22, 2025 | SOpen-market sale Common Stock10b5-1 | -2,208 | $40.58 | $90k | 38,867 | Sep 23, 2025 |
| Sep 22, 2025 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -2,208 | $0.00 | $0 | 70,667 | Sep 23, 2025 |
Related signals
Other insiders at Avidity Biosciences, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | Avidity Biosciences, Inc. | Steven George Hughes Chief Medical Officer | $105k 2,209 shares | -5% | |
| 25Weak | Avidity Biosciences, Inc. | Teresa McCarthy Chief Human Resources Officer | $1.0M 20,000 shares | -17% | |
| 14Weak | Avidity Biosciences, Inc. | Eric Mosbrooker Chief Commercial Officer | $298k 6,562 shares | -11% | |
| 3Weak | Avidity Biosciences, Inc. | Steven George Hughes Chief Medical Officer | $70k 1,542 shares | -4% | |
| 20Weak | Avidity Biosciences, Inc. | Teresa McCarthy Chief Human Resources Officer | $621k 15,000 shares | -13% | |
| 22Weak | Avidity Biosciences, Inc. | W. Michael Flanagan Chief Scientific Officer | $779k 20,000 shares | -20% | |
| 30Weak | Avidity Biosciences, Inc. | Troy Edward Wilson director | $1.5M 29,500 shares | -35% | |
| 14Weak | Avidity Biosciences, Inc. | Eric Mosbrooker Chief Commercial Officer | $309k 6,563 shares | -11% | |
| 35Weak | Avidity Biosciences, Inc. | Sarah Boyce President and CEO | $2.5M 50,000 shares | -14% | |
| 10Weak | Avidity Biosciences, Inc. | Kathleen P. Gallagher Chief Program Officer | $8,915 188 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.